Rs.150 Million New Bulk Drug Intermediates & Specialty Chemicals Mfg. Unit in Thane, Maharashtra
A pharmaceutical company plans to establish an API intermediates manufacturing unit in Maharashtra with a capacity of 144 MTPA, involving an estimated cost of Rs. 46.8 million. Construction will take place between November and December 2023. The project has expanded to include bulk drug intermediates and specialty chemicals with an investment of Rs. 150 million. Environmental clearance is underway.
View project